I am the Group Leader of Experimental Radiobiology at the Department of Oncology. As a researcher, I study radiotherapy for cancer, particularly proton therapy. I investigate how radiation affects healthy tissues and how we can reduce side effects and make treatment gentler. My background is in biology, and I have extensive experience in experimental cancer research. I collaborate with doctors, physicists and other researchers to translate laboratory findings into better treatment for patients.
I study radiotherapy for cancer, with a particular focus on proton therapy and damage to healthy tissues. Through laboratory and animal experiments, I investigate how radiation affects tissues and how we can reduce the risk of side effects, including when patients receive repeat radiotherapy. My research helps doctors and physicists plan treatment so that cancer patients can receive effective radiotherapy with fewer side effects.
My primary area of responsibility is research into radiotherapy for cancer, including proton therapy and the effects of radiation on healthy tissues. I investigate how dose and treatment scheduling influence the risk of side effects, including when patients receive repeat radiotherapy. I also plan and conduct laboratory and animal experiments, teach and supervise students and early-career researchers, and collaborate on translating research findings into better patient treatment.
